Cargando…

De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor

Detalles Bibliográficos
Autores principales:	Morel, Adeline, Masliah-Planchon, Julien, Bataillon, Guillaume, Becette, Véronique, Morel, Claire, Antonio, Samantha, Girard, Elodie, Bièche, Ivan, Le Tourneau, Christophe, Kamal, Maud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446375/ https://www.ncbi.nlm.nih.gov/pubmed/32914015 http://dx.doi.org/10.1200/PO.18.00398

Ejemplares similares

Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site
por: Kamal, Maud, et al.
Publicado: (2020)

Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site
por: Kamal, Maud, et al.
Publicado: (2023)

ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment
por: Dessources, Kimberly, et al.
Publicado: (2022)

Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance
por: Hescot, Ségolène, et al.
Publicado: (2022)

Identification of a large intra-exonic deletion in BRCA2 exon 18 in a pancreatic ductal adenocarcinoma
por: Debbabi, Inès, et al.
Publicado: (2023)

Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie
por: Basse, Clémence, et al.
Publicado: (2018)

Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer
por: Vacher, Sophie, et al.
Publicado: (2020)

Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants
por: Villy, M.-C., et al.
Publicado: (2021)

Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer
por: Tury, Sandrine, et al.
Publicado: (2016)

Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types
por: Azorin, Paula, et al.
Publicado: (2022)

Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome
por: Kamal, Maud, et al.
Publicado: (2018)

Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations
por: Lopez-Knowles, Elena, et al.
Publicado: (2018)

Fine‐needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next‐generation sequencing in cancer patients included in the SHIVA02 trial
por: Dupain, Célia, et al.
Publicado: (2020)

Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung Cancer
por: Basse, Clémence, et al.
Publicado: (2023)

MBRS-47. RAPID MOLECULAR SUBGROUPING OF MEDULLOBLASTOMA BASED ON DNA METHYLATION BY NANOPORE SEQUENCING
por: Masliah-Planchon, Julien, et al.
Publicado: (2020)

Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients
por: Allouchery, Violette, et al.
Publicado: (2018)

Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor
por: Clatot, Florian, et al.
Publicado: (2016)

Unusually Aggressive Actinic Keratosis of the Eyelid and Conjunctiva
por: AL-HAGE, Jana, et al.
Publicado: (2023)

Aromatase cytochrome P450 gene expression in endometrial carcinoma.
por: Sasano, H., et al.
Publicado: (1996)

Increased frequency of ESR1 mutation in metastatic breast cancer by dosing selective estrogen receptor modulator followed by aromatase inhibitor
por: Takeshima, Kaoru, et al.
Publicado: (2020)

Early repolarization syndrome caused by de novo duplication of KCND3 detected by next-generation sequencing
por: Chauveau, Samuel, et al.
Publicado: (2017)

The ESR Patient Advisory Group (ESR-PAG)
Publicado: (2015)

Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival
por: Einarsdóttir, K, et al.
Publicado: (2009)

Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
por: Gougis, Paul, et al.
Publicado: (2019)

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas
por: Crowley, Fionnuala, et al.
Publicado: (2022)

ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor–Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy
por: Reinert, Tomás, et al.
Publicado: (2020)

Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma
por: Mainguené, Juliette, et al.
Publicado: (2022)

High-grade childhood intra-parenchymal brain tumor clustering with ATRT and expanding the cancer spectrum related to inherited SMARCE1 truncating variations
por: Forest, Fabien, et al.
Publicado: (2022)

Deep intronic hotspot variant explaining rhabdoid tumor predisposition syndrome in two patients with atypical teratoid and rhabdoid tumor
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2017)

ESR1 and ESR2 genotypes and the age at menarche in idiopathic scoliosis
por: Janusz, Piotr, et al.
Publicado: (2014)

Stochastic Cooling at the ESR
por: Beckert, Karl, et al.
Publicado: (2000)

Stochastic cooling at the ESR
por: Beckert, K, et al.
Publicado: (1999)

Eruptive keloids associated with aromatase inhibitor therapy
por: Meade, Cathy, et al.
Publicado: (2015)

Mechanistic Signatures of Human Papillomavirus Insertions in Anal Squamous Cell Carcinomas
por: Morel, Adeline, et al.
Publicado: (2019)

Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma
por: Drouyer, Aurélien, et al.
Publicado: (2023)

RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action
por: Masliah-Planchon, Julien, et al.
Publicado: (2015)

Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery
por: Moreira, A., et al.
Publicado: (2021)

Long-Term Effect of Aromatase Inhibition in Aromatase Excess Syndrome
por: Binder, Gerhard, et al.
Publicado: (2021)

Overexpression of the stathmin gene in a subset of human breast cancer.
por: Bièche, I., et al.
Publicado: (1998)

Symmetry-related residues as promising hotspots for the evolution of de novo oligomeric enzymes
por: Yu, Jaeseung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t9geo7f0dkfu70tpmhki26ribf